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ABSTRACT
Evidence for the Regulation of
Luteinizing Hormone-Sensitive
Adenylate Cyclase
By Mono- and Divalent Cations
Steven David Gore
1984
The actions of pharmacologic agents which alter cellular cation levels
were examined in dispersed, enriched rat luteal cells to determine to what
extent changes in transmembrane ion gradients or ion fluxes affected the
response of the luteal cell to luteinizing hormone (LH).

Ouabain, which

depletes sodium and potassium gradients between cells and media by inhibition
of the Na+ , K+ -ATPase, inonensin, a monovalent ionophore which shows high
specificity for sodium, and valinomycin, a potassium ionophore, were found to
produce significant, dose-dependent inhibition of LH-stimulated cAMP ana
progesterone production.

Little effect of these agents was seen on

unstimulated cAMP and progesterone production.

Half-maximal inhibition (ID

50) for ouabain was about 50 uM and maximal inhibition was about 50% (200
yM).

For monensin, the ID 50 was about 0.1 uM ana maximal inhibition was

greater than 60% (1 yM); for valinomycin, the ID 50 was less than 10 nM and
maximum inhibition was about 60% (10 nM).

Inhibition by ouabain and monensin

was not overcome by high doses of LH (1 yg/ml).

None of the drugs affected

cell viability as judged by trypan blue exclusion or release of lactate
dehydrogenase into the medium.
Binding and uptake of human chorionic gonadotropin (hCG) by luteal cells
was not affectea by drug treatment.

Ouabain and monensin showed no inhibition

of basal or LH-stimulatea adenylate cyclase activity in membrane preparations.

and inhibition of phosphodiesterase by isobutyl methylxanthine did not reverse
the inhibitory effects of the three drugs.

Ouabain and monensin inhibited

progesterone accumulation in response to dibutyryl cAMP, while valinomycin had
no effect on post- cAMP events in steroidogenesis.

Incubation of cells in

medium in which sodium was replaced by choline completely reverse the
inhibition due to ouabain or monensin, while valinomycin was still inhibitory
in the absence of extracellular sodium, consistent with the known
pharmacological actions of these drugs.
Stimulation of luteal cAMP accumulation by cholera toxin was unaffected by
ouabain treatment; however, monensin significantly inhibited cholera
toxin-stimulated cAMP accumulation.

Forskolin, which stimulates mammalian

adenylate cyclase systems by interaction with the catalytic subunit,
significantly increased luteal cAMP production but had a much less pronounced
effect on steroidogenesis.

Ouabain and prostaglandin

(PG F^a) did not

inhibit cAMP accumulation in response to forskolin, although monensin showed
significant inhibition.

Like PG F^, ouabain appears to inhibit coupling of

the hormone-receptor complex to the catalytic subunit of adenylate cyclase.
Monensin inhibition appears to be at the catalytic subunit, although proximal
sites of inhibition are also possible.
Luteal cell response to LH did not appear to require acute sodium influx
as substantial reduction of extracellular sodium (to 32 meq/1) had no effect
on LH stimulation; tetrodotoxin (1 pM) was also without effect.

Reversal of

the sodium gradient by substitution of choline for extracellular sodium led to
30% inhibition of LH-stimulated cAMP accumulation.

Depolarization of luteal

cells with high concentrations of extracel 1 ular potassium (66 meq/1) did not
affect LH-stimulation.

Incubation of cells in Ca++ -free medium decreased

unstimulated cAMP levels and blunted the cAMP response of cells to LH.
Neither ouabain nor monensin were inhibitory in the absence of extracellular
calcium.

Inhibition by low doses of ouabain or monensin was super-additive

with low doses of PG F„ .
2a

It is possible that PG F„

2a

shares a common

pharmacological mechanism with ouabain and monensin; this may be an increase
in free cytoplasmic calcium.

Combinations of maximal doses of PG F^a and

maximal doses of ouabain or monensin were less inhibitory than either agent
alone.

The antigonadotropic effect of PG F^a did not require extracellular

sodium.
It is concluded that the response of luteal cells to LH is critically
dependent on maintainance of normal ionic gradients.

Pharmacologic maneuvers

which increase intracellular calcium appear to inhibit the response of luteal
adenylate cyclase to LH.

Since the LH response is blunted in the absence of

calcium, the details of calcium-cAMP interaction in the luteal cell are likely
to be complex; such interactions may play a crucial role in luteolysis which
is initiated by suppression of LH-stimulated cAMP accumulation and
progesterone secretion.
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1
INTRODUCTION

Maintainance of a secretory endometrium which can support a developing
embryo requires the steroid hormone, progesterone, which is synthesized by the
cyclically formed corpus 1uteum.

In the absence of fertilization and

implantation, serum progesterone concentrations fall, the endometrium is
sloughed, and a new estrous cycle begins.

The corpus luteum has a critical

role in maintaining pregnancy and in regulating the estrous and menstrual
cycles.

A primary function of this organ is the production of steroid

hormones, predominantly progesterone.
The cessation of progesterone secretion and gradual involution of the
gland in the absence of pregnancy are essential for the beginning of a new
cycle and ovulation.

Consequently, the control of the steroidogenic apparatus

of the corpus luteum is central to the regulation of mammalian reproductive
cycles.
The factors which maintain the corpus luteum vary among species, however,
prolactin and luteinizing hormone (LH) are required to a greater or lesser
extent in most species (1,2).

The rat corpus luteum requires an intact

pituitary to maintain steroidogenesis; both hypophysectomy and treatment with
2-Br-ergocryptine, a prolactin secretion inhibitor, prevent progesterone
secretion (1,2).

Treatment with exogenous prolactin will maintain corpus

luteum function after hypophysectomy, however prolactin does not itself
stimulate steroidogenesis (1).

Prolactin is thought to be a permissive

luteotropin, facilitating progesterone production without determining the rate
of release of the hormone (2).

The cellular mechanism of prolactin action is

not well understood; however, prolactin helps maintain levels of cholesterol

.
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ester synthetase and cholesterol esterase, enzymes involved in the
maintainance of adequate substrate levels for steroidogenesis (3).
also inhibits synthesis of

3$

-and

20a-

Prolactin

steroid dehydrogenases, enzymes which

metabolize progesterone to inactive products (4).

Prolactin also plays a role

in maintaining luteal receptors for LH, enabling the organ to respond to this
trophic hormone (5,6).
On days 6-9 of pregnancy, prolactin will no longer sustain corpus luteum
function in hypophysectomized rats unless supplemented by LH (1).
days, LH is the predominant luteotropin (1,7).

After 8

In contrast to prolactin, LH

is a stimulatory luteotropin which determines the rate and extent of
progesterone production in a direct, dose-dependent fashion (2).

Like those

of many peptide hormones, the actions of LH are thought to be mediated by cAMP
(8).

Fulfilling Sutherland's criteria for a cyclic AMP - mediated system (9),

LH increases cAMP accumulation by the corpus luteum, and both exogenous cAMP
and phosphodiesterase inhibitors stimulate luteal steroidogenesis (8).
Membranes prepared from corpora lutea exhibit adenylate cyclase activity which
can be stimulated by LH (10).
Although cyclic AMP mimics the steroidogenic effects of LH, the precise
relationship between LH, cAMP, and luteal steroidogenesis remains unclear.
Marsh and colleagues demonstrated a dissociation between the dose-response
curves for the stimulation of progesterone accumulation and cAMP accumulation
by LH (11).

In particular, progesterone accumulation was stimulated by a

concentration of LH which was a full order of magnitude less than that
required to detect a significant increase in cAMP accumulation.

Similar

dissociation of cAMP and steroid accumulation has been noted for ACTH

.
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stimulation of the adrenal, LH stimulation of testis, and TSH stimulation of
thyroid (8).

Three mechanisms have been invoked to explain this

dissociation.

The spare receptor hypothesis postulates that only a small

percentage of hormone receptors need to be occupied for a fractional
activation of adenylate cyclase to maximally stimulate progesterone
accumulation.

The bulk of receptors and adenylate cyclase molecules are, in

effect, a spare pool, guaranteeing that the cell will respond to low levels of
hormone.

The second hypothesis is that hormone binding induces formation of a

small amount of cAMP which is not detectable above baseline levels, but which
is confined to a small intracellular compartment with priveledged access to
steroidogenic machinery.

The third hypothesis states that cAMP-dependent

protein kinase can be activated by an undetectable increase in cellular cAMP
(8,11,12).

This issue has not been resolved experimentally, and it remains

possible that there are other intracellular messengers which mediate the
steroidogenic effects of LH.

It is also conceivable that cAMP formed at

higher doses of hormone serves other, as yet unidentified, cellular
functions.
The production of cyclic AMP is the end result of interaction of a complex
of integral membrane proteins, together known as adenylate cyclase, and
currently thought to consist of three components.

The catalytic moiety,

responsible for enzymatic conversion of ATP to cAMP, is inactive unless
activity is conferred by a second protein, know as G/F or N.

This "coupling

protein" possesses GTPase activity and is the site of activation of adenylate
cyclase by fluoride ion and by cholera toxin.

In the presence of guanine

nucleotides, N enables the hormone-receptor complex to activate the catalytic

4.

subunit.

There is considerable debate about the details of the coupling

mechanism (13).
Although early studies suggested that the luteal cyclase system might
differ from other mammalian cyclases in significant ways, the luteal enzyme
now appears to be quite similar.

Like other cyclases, luteal adenylate

cyclase in membrane preparations demonstrates a requirement for ATP and
magnesium ion (10).

The luteal enzyme exhibits considerable basal activity

and is stimulated 2-4 fold by LH, prostaglandin

and epinephrine (10).

In

contrast to other cyclase systems, a requirement for guanine nucleotides for
hormonal stimulation was not demonstrated originally (10).

More recent

studies have demonstrated that guanine nucleotides control basal activity of
luteal adenylate cyclase as well as the responsiveness of the enzyme to
hormones.

In the absence of guanine nucleotides, LH, human chorionic

gonadotropin (hCG),

and isoprotereno I caused only a marginal stimulation of

cyclase, whereas addition of GTP or GTP analogues led to a 3-4 fold
stimulation by hormones (14).

Additionally, early studies concluded that

hormonal sensitivity of the luteal cyclase showed marked dependence on ATP
concentration (10); recent studies indicate that this effect is due to the
buffering of the magnesium concentration by ATP.

Activation of luteal cyclase

appears to be extremely sensitive to the concentration of free magnesium ion;
addition of substances such as ATP and inorganic phosphate which act as
magnesium buffers in the 10- 100 uM range permit stimulation of cyclase over a
broader range of added MgC 1 ^ (14).
. cyclase activity are not additive.

The effects of LH and isoproterenol on
This indicates that there is only one form

of catalytic subunit of luteal cyclase, which is activated by various occupied
hormone receptors (14).

.
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Although it is presumed that luteal steroidogenesis is stimulated by a
cAMP-dependent protein phosphorylation, the details of this process are not
completely understood.

Attention has focussed on two loci for stimulation of

steroid production: the availability of free cholesterol to act as a substrate
for mitochondrial pregnenolone production, and the rate of the cholesterol
side chain cleavage reaction (CSCC) which forms pregnenolone from
cholesterol.

CSCC is the rate-limiting reaction in steroidogenesis (15).

Behrman and Armstrong demonstrated an increase in cholesterol esterase
activity in luteinized ovaries from rats treated with LH (16).

Administration

of LH reduced luteal cholesterol ester concentration in control rats and in
rats treated with aminoglutethimide, an inhibitor of CSCC (17).

This

indicated that LH could mobilize substrate stored as cholesterol ester, even
when CSCC was inhibited, preventing metabolism of cholesterol.

Caffrey and

colleagues showed that luteal cholesterol esterase activity in cell
homogenates was stimulated by dibutyryl cAMP (

(BuJ^cAMP) in the presence

of magnesium and ATP, suggesting that the esterase was stimulated by an
endogenous protein kinase (18).

In addition, cholesterol esterase activity

measured during the estrous cycle correlated well with serum progesterone
levels and luteal tissue progesterone (18).
Curon et al

solubilized the cytochrome P450 system from bovine corpora

1utea mitochondria and reconstituted the CSCC using purified components from
adrenal cortex.

Addition of protein kinase partially purified from bovine

corpora ,1 utea increased conversion of cholesterol to pregnenolone in the
presence of ATP and cAMP (14).

Downing and Dimino added partially purified

protein kinase from a crude preparation of CSCC complex from porcine luteal

.
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mitochondria and noted an increase in cholesterol conversion activity (20).
Mori and Marsh studied cholesterol metabolism in mitochondria of rat corpora
lutea.

In rats treated with aminoglutethimide, LH treatment increased

mitochondrial cholesterol, in agreement with previous studies.

In the absence

of inhibitor, LH decreased cholesterol levels, suggesting that the hormone
also promoted cholesterol metabolism.
treatment was indeed observed.

An increase in CSCC activity after LH

These investigators further demonstrated that

the initial rate of cholesterol conversion did not correlate with
mitochondrial cholesterol concentration.

In addition, the rate of conversion

was slowed markedly without depletion of the majority of mitochondrial
cholesterol.

The authors postulate that LH treatment not only increased

mitochondrial cholesterol and CSCC activity, but increased the fraction of
cholesterol which was available for steroidogenesis (21).
Regression of the corpus lutuem, or luteolysis, is marked by a sharp
decrease in serum progesterone, and increased secretion of its metabolite
20a-hydroxyprogesterone.

Biochemical signs of luteolysis are followd by

histological changes indicative of organ involution (22).
rat can be induced by administration of prostaglandin F^
there is considerable evidence that PG F9

Luteolysis in the
(PG F^), and

is the predominant luteolytic

signal in the rat and many other species (23).

PG F9

is thought to be

synthesized in the uterus and transferred to the ovary via counter-current
exchange between the uterine vein and ovarian artery (23).

There is evidence,

however, that the rat corpus luteum contains prostaglandins and can synthesize
them (24,25).

It is possible that both organs contribute physiological ly

important prostaglandins.

.
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PG

antagonizes the ability of luteal cells to increase cAMP

accumulation in response to luteinizing hormone.

This was initially shown by

Grinwich et al who demonstrated that coincubation of rat luteal slices with PG
F0

2a

and LH diminished the rise in cAMP seen with LH alone (26).

These

results were confirmed by Lahav et al. working with intact corpora lutea in
culture (27).
'

'

In isolated luteal cells, PG F0

£OL

stimulates basal

progesterone accumulation but antagonizes the ability of LH to increase cAMP
and progesterone accumulation (28).

PG

a^so diminishes progesterone

accumulation in response to (Bu)t>cAMP, indicating that PG F^ inhibits
steroidogenesis at two loci: formation of cAMP, and post-cAMP steroidogenesis
(29) .

PG F^a completely inhibits steroidogenesis in response to cholera

toxin but only partially reduces cAMP accumulation in response to the toxin
(30) .
PG F0

does not affect binding of [125I]-hCG to luteal cells (29) nor

C- OL

does it affect the ability of LH to stimulate adenylate cyclase in luteal
membrane preparations (31).

When membranes were prepared from corpora lutea

which had been incubated in vitro with PG F0

ca

for 15 to 60 minutes, both

basal and LH-stimulated adenylate cyclase activity was reduced; moreover,
fold-stimulation by LH was reduced by approximately one half (32).
while PG F0

ca

Thus,

does riot appear to have a direct effect on LH-stimulated

cyclase in membrane preparations, the prostaglandin may induce cellular
changes which modulate the responsiveness of the enzyme complex to LH.

In

addition to the biochemical changes seen in response to acute treatment with
PG F^ , later changes induced by administration of prostaglandin to rats
include decrease in uptake of hCG and prolactin by corpora lutea (6), a

.
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decrease in LH receptors (33), and decreased blood flow to the corpus luteum
(34).
Other factors are known to modulate the responsiveness of the corpus
luteum to LH.

Clayton et al reported that an agonistic analog of gonadotropin

releasing hormone (GnRH) was bound specifically to dispersed rat luteal cells
and inhibited hCG-stimulated progesterone secretion (35).

Subsequent studies

by Behrman et al. demonstrated that GnRH and agonistic analogs antagonized
LH-stimulated cAMP and progesterone accumulation in rat luteal cells (36).
Like prostaglandin, GnRH did not affect hCG binding to luteal membranes or LHstimulated adenylate cyclase in membrane preparations (36).

LH-stimulation of

cAMP and progesterone accumulation has been found to be amplified by adenosine
and other purines (37).

Adenosine had little effect in the absence of LH and

was able to reverse PG

a inhibition in an apparently competitive manner

(38).

Unlike purine stimulation of adenylate cyclase in other cell types in

which adenosine stimulates cyclase via a membrane receptor exposed to the
extracellular space (39), adenosine stimulation in luteal cells requires
intracellular uptake of adenosine (37).

The dose-response and time course

characteristics of purine amplification of LH action correspond to the ability
of these compounds to stimulate cellular ATP levels, suggesting that
increasing substrate availability for cyclic AMP synthesis may be one
mechanism by which purines exert their effect (40).

The physiologic

importance of GnRH and purine modulation of luteal function is still
speculative.
The response of the luteal cell adenylate cyclase and steroidogenic
apparatus to luteinizing hormone is clearly modulated by many factors.

The

.
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plasticity of the luteal cell response to LH may well confer upon the corpus
luteum its ability to regulate the post-ovulatory events of the mammalian
reproductive cycle.

The serum levels of LH and prolactin do not decrease at

the time of physiologic luteolysis (41); local factors must be responsible for
the early stages of luteolysis.
The mechanisms by which the paracrine regulators modulate the cellular
response to LH are unknown.

As discussed above, neither PG

nor GnRH

affect hCG binding to the LH receptor, nor do they affect stimulation of
adenylate cyclase by LH in membrane preparations.
luteal tissue with PG F„

2a

Further, incubation of

before preparation of membranes decreases

LH-stimulated cyclase activity in membranes.

It would appear that cellular

integrity is required for modulation of LH stimulation.

X-ray diffraction

studies of rat and bovine microsomal membranes prepared from corpora lutea
have shown that in vivo treatment with PG F0

leads to an increase in the

transition temperature of the membranes, indicative of a decrease in membrane
fluidity (42,43,44).

The authors of these papers have postulated that PG

F^a decreases membrane fluidity, thereby restricting lateral diffusion of
membrane proteins and perhaps preventing interaction of the three components
of adenylate cyclase.

How this apparent fluidity change arises is uncertain;

lipid composition of the membranes was apparently unchanged (43).
Confirmation of membrane fluidity changes upon PG F^ treatment in cells
would help clarify whether this might be an important mechanism in PG F9 induced luteolysis.
Dorflinger and Behrman have reported that treatment of luteal cells with
the calcium inophore A23187 inhibits cAMP and progesterone accumulation in

response to LH.

Additionally, millimolar doses of calcium inhibit

LH-stimulated cAMP accumulation in membrane preparations (31).
investigators have suggested that PG

These

action is mediated by calcium

influx or by mobilization of intracellular calcium.

Substantial evidence

indicates that pituitary gonadotropin release induced by GnRH is mediated by
calcium influx (45).

Although GnRH mimics the inhibitory actions of PG

on luteal cells, experiments with slices of luteal tissue have suggested that
depolarization of luteal cells actually increases steroidogenesis in a
calcium-dependent manner (46).

In porcine granulosa cells, removal of

extracellular calcium diminishes LH-stimulated cAMP and progesterone
secretion, and treatment with A23187 augments LH-stimulated steroidogenesis
(47).
The experiments in this thesis were designed to further elucidate the
importance of transmembrane ion flux and membrane potential to the response of
luteal cells to LH.

The effects of three pharmacologic agents which perturb

normal ionic gradients have been studied.

The cardiac glycoside ouabain, by

inhibiting the Na+, K+ -ATPase, allows sodium and potassium to diffuse
according to their electrochemical gradients.

Monensin is a monovalent

cationophore with high selectivity for sodium (48).
potassium ionophore (48).

Valinomycin is a

.
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MATERIALS AND METHODS
ANIMALS
Immature (26-27 days old) female rats (CD strain, Charles River
Laboratories, Wilmington, Massachusetts) were injected subcutaneously with 50
IU pregnant mare serum gonadotropin (Gestyl, Organon Pharmaceuticals, West
Orange, New Jersey).

Sixty hours later, 25 IU human chorionic gonadotropin

(hCG) (A.P.L., Ayerst Laboratories, Rouses Point, New York) was injected.

DISPERSION, ENRICHMENT AND INCUBATION OF LUTEAL CELLS
Isolated luteal cells were prepared as described by Thomas et al. with
some modifications (28).

All media used for cell dispersion and incubation

contained bovine serum albumin (Fraction V, Calbiochem, La Jolla, California)
at a concentration of 0.1%.

Ovaries were removed 4-6 days following hCG

injection, minced by razor and dispersed in 5 ml calcium-free MEM (Medium 1,
1380, Grand Island Biological Company, Grand Island, New York), containing
2000 IU collagenase (Worthington Biochernicals Corporation, Freehold, New
Jersey) and

3000 IU deoxyribonuclease (Worthington) per g tissue for 1 h at

37° under 95% 0^ - 5% CO^.

The cells were centrifuged for 5 min. at 100

X g and resuspended in medium 1 containing EDTA (1.1 mM) for two minutes and
recentrifuged.

The supernatant was discardea, the cells were resuspended in

medium 1 and filtered through nylon mesh (Nyten, Tetko, Inc., Elmsford, New
York).

The cells were again centrifuged for 5 min. and the pellet resuspended

in 1.5ml medium 1.
The luteal cell population was enriched by centrifugation on a
discontinuous density gradient (Percoll, Pharmacia Fine Chemicals, Uppsala,

.
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Sweden) at room temperature as described (36).

The cells present within the

density layers of 1.018 and 1.003 g/ml were aspirated and pooled and washed
with 12 ml medium 1, then centrifuged at 100 X g for 10 min.

The cells were

resuspended in MEM with 25 mM HEPES and Earles' salts (medium 2, 2360, Grand
Island Biologicals Co.).

Based upon size and lipid inclusions, luteal cells

comprised more than 80% of total cells and virtually no blood cell
contamination was evident.

Cell number was determined with a hemacytometer

and cell viability was greater than 90% as assessed by the trypan blue test
(49).
Cells were incubated in 12 X 75 mm glass culture tubes at 8 X 10
X 10

5

cells/tube in a final volume of one ml medium 2 at 37

atmosphere of 95% 0^-5% C0^.

o

4

to 1.2

under an

Additions of hormones and drugs as indicated

in the text were made in medium 2.

After various incubation times the culture

tubes were immersed in a boiling water bath for 10 min. and stored at -20°C
until analyzed.
In experiments in which the sodium concentration was altered, medium 2 was
prepared in which all sodium salts were replaced isotonically with choline
chloride.

The composition of other salts, amino acids and vitamins was

identical to MEM with Earle's salts (medium 2).

Cell suspensions were divided

into aliquots and centrifuged at 100 X g for 5 min.

The medium was discarded,

and the cells were resuspended in prepared media with various sodium
concentrations.

After incubating for 5 min at 37°, the cells were

recentrifuged, and the washing procedure repeated.

.
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ADENYLATE CYCLASE ASSAY
LH-sensitive adenylate cyclase activity was assayed essentially as
described by Birnbaumer (20) with modification for RIA as described earlier
(37).

Membranes were prepared from ovaries removed 7-8 days following hCG

injection by homogenization at 0°C in a buffer containing 27% sucrose, 1 mM
EDTA, 10 mM Tri s HC1, pH 7.5, at 5 ml/g tissue.

The homogenate was filtered

through nylon mesh (Nyten, Tetko, Inc.) and centrifuged at 1000 X g for 10 min
at 4° C.

The supernatant was recentrifugea at 10,000 X g for 30 min.

The

pellet was resuspended and quick frozen in dry ice-isopropanol and stored at
-70° C.
For assay, membranes were thawed and centrifuged at 10,000 X g for 30 min
at 0° C.

The pellet was resuspended at 7 ml/g tissue and 40 yl membrane

suspension was incubated in a final reaction mixture volume of 100 yl.

The

final concentrations of reagents were: 10.8% sucrose, 4 mM Tris HC1, 15 mM
bis-tris-propane, pH 7.5, 1 mM EDTA, 20 mM creatine phosphate, 0.2 mg/ml
creatine phosphokinase, 0.1 mg/ml myokinase, 2 mM MgCl^* 0.01% bovine serum
albumin.

Additions of other drugs and hormones are indicated in the text.

The reaction was initiated by addition of ATP (final concentration 3 mM) and
incubated at 37°C for 10 min.

The incubation was terminated by placing

tubes in boiling water for 10 min.

Aliquots were removed and assayed for cAMP

by RIA as indicated below.

ASSAYS OF cAMP AND PROGESTERONE
The RIA of cAMP was based on the procedure of Steiner (50) using a kit,
(Schwartz/Mann, Orangeburg, New York).

The assay was sensitive to 0.1 pmol

.
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with minimal cross reaction to other nucleotides (ATP, 0.0001%, AMP 0.001%,
cGMP 0.01%).

Progesterone production was assayed by RIA as described

previously (51).

IPS

BINDING AND UPTAKE OF [ ^IJ-hCG TO LUTEAL CELLS
Binding studies were performed as described earlier (36).

[

125

I]-hCG

was prepared by the lactoperoxidase method as described earlier (33).
was diluted in medium 2 and added to 1-3 X 10
0.5 ml in 12 X 75 mm glass culture tubes.
the text.

5

Tracer

cells in a final volume of

Other additions are described in

Cells were incubated for 3 h at 37°C under 95%02~5% CO^; 2 ml

medium 2 was added to each tube, and the cells were centrifuged at 100 X g for
5 min.

The supernatant fraction was aspirated and the radioactivity in the

pellet determined.

Non-specific binding was defined as radioactivity

associated with cells incubated in the presence of 1000 mill hCG.

OTHER ASSAYS
Lactate dehydrogenase activity was assayed in medium or in cells lysed
hypotonically by the spectrophotometric assay of Wacker (52) using a kit
(Statzyme, Worthington).
blue method (49).

Cell viability was also assessed using the trypan

Protein was assayed by the Bradford method (53).

HORMONES, DRUGS, AND REAGENTS
Ovine LH (NIADDK - oL H 23)was a gift from NIH (Bethesda, Maryland). oLH
was dissolved in 10 mM Tris HC1, pH 7.5, with 0.1% BSA, at 100 ug/ml.
Aliquots were stored at -70°C.

hCG (A.P.L., Ayerst Laboratories) was

.
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dissolved in 40 mM Tris HCl pH 7.4 with 5 mM MgSO^ at 1000 IU/ml and
aliquots were stored at -4°C.

Ouabain and valinomycin were purchased from

Sigma (St. Louis, Missouri) and monensin was purchased from Calbiochem.
Cholera toxin was purchased from Sigma, and forskolin from Calbiochem.
Adenylate cyclase assay reagents were from Sigma.

PG F^ tromethamine salt

was a gift from Dr. John Pike (Upjohn Co., Kalamazoo, Michigan).
4 mM stock solutions of ionophores were prepared in ethanol and stored at
-4°C.

Ionophores were diluted in medium 2 before addition to cells, and

final concentration of ethanol never exceeded 0.01%.

Solutions of ouabain

were made in medium 2 on the day of the experiment.

Forskolin was dissolved

in ethanol (10 mM) and stored at -4°C.

STATISTICAL ANALYSIS
Luteal cells from several animals were pooled and samples of equal numbers
of cells were exposed to various treatments within an experiment.

Data are

reported as the mean + SEM for four replicates of representative experiments.
The two-tailed t test for paired data was used to test differences between
samples.

Pairs were based on the sequence of replicate incubations within

each treatment group.
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RESULTS
Preincubation of dispersed, enriched luteal cells with ouabain caused
significant, dose-dependent inhibition of LH-stimulated cAMP and progesterone
accumulation (Figure 1).

Maximal inhibition of LH-stimulated cAMP and

progesterone accumulation was about 50% at a ouabain concentration of 200 yM.
Half-maximal inhibition occurred at 50yM ouabain.

In Figure 2, dose-response

curves of ouabain inhibition of cAMP and progesterone accumulation in the
presence of increasing doses of LH are plotted.

No consistent effect of

ouabain was seen on unstimulated cAMP or progesterone accumulation, although
occasional, slight inhibition or stimulation was observed.

Ouabain inhibition

was greatest at low doses of LH (71.5% at LH = 10 ng/ml) but was still
significant at high doses of LH (35% at LH = 1000 ng/ml).

A plot of the

reciprocal of cAMP accumulation against drug concentration with 10 and 100
ng/ml of LH illustrated that ouabain inhibition of LH-stimulated cAMP
accumulation was competitive with a

of about 20yM (90).

The estimated

K.. for ouabain inhibition of LH-stimulated progesterone secretion was 10-15
uM.

This value was obtained from a plot of the reciprocal value of maximal

progesterone secretion against the concentration of inhibitor, based on the
assumption that inhibition was competitive.

Although lower, the K. for

inhibition of progesterone secretion compares reasonably well with the
for inhiDition of cAMP accumulation.

In early experiments, cells were

incubated with ouabain for 1 h before the addition of LH, however, identical
inhibition was seen with 10 min. preincubation (see Table 4), and in later
experiments, 20 min. preincubations of cells with ouabain were used
routinely.
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Incubation of cells with 100 yM ouabain for 2 h did not affect cell
viability as judged by the exclusion of trypan blue or by the release of the
cytoplasmic enzyme, lactate dehydrogenase (data not shown).

The reversibi1ity

of ouabain inhibition was tested in the following manner. Cells were incubated
with ouabain (100 uM) for 15 min., the media was removed following
centrifugation (100 x g, 5 min.), the cells resuspended in fresh medium with
or without ouabain, and incubated for an additional 5 min.

The washing

procedure was then repeated, the cells were resuspended in media with or
without ouabain, LH was added 5 min. after resuspension of the cells, and the
incubation was continued for 90 min.

As shown in Table 1, inhibition of cAMP

accumulation was 67 + 7% in the treated samples and 37 + 4% in the washed
samples.

In a separate experiment, inhibition of progesterone accumulation

was reduced from 76 + 3% in the samples which were washed and retreated to 18
+ 3% in the washed samples.

The differences between washed and retreated

samples were significant (p<0.05).
There are several loci at which ouabain might inhibit LH-stimulation,
including: binding of hormone to receptor, interaction of hormone-receptor
complex to the N subunit of adenylate cyclase, interaction of the subunit with
the catalytic moiety of the enzyme, or at the catalytic subunit directly.
Inhibition could also be mediated by an increase in phosphodiesterase
activity.

Additionally, progesterone accumulation could be inhibited at sites

distal to cAMP accumulation.

Several experiments were performed to assess to

possible site of inhibition by ouabain.
First, the effects of ouabain on the binding and uptake of hormone by
cells was tested.

Cells were incubated with ouabain (100 yM) for 20 min.
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before addition of [
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I]-hCG and various amounts of unlabeled LH.

Incubation and determination of bound radioactivity then proceeded as
described in Methods.

Treatment with ouabain had no significant effect on the

binding of labeled ligand or on competition for binding with unlabeled hormone
(data not shown).

Ouabain treatment therefore, does not appear to affect

interaction of hormone with receptor.
Next, the effect of ouabain on adenylate cyclase activity was studied in
membrane preparations as described in Methods.

Table 2 demonstrates that

ouabain (100 yM) had no significant effect on either basal or LH-stimulated
adenylate cyclase activity in membrane preparations.
The possibility that ouabain treatment decreased cAMP accumulation by
increasing metabolism of the nucleotide was also considered.

Cells were

preincubated in the presence or absence of the cyclic nucleotide
phosphodiesterase inhibitor isobutyl methylxanthine (IBMX, lOO^M) for 10
min.

Ouabain (100 uM) was then added, and incubation continued for an

additional 20 min. before the addition of LH (100 ng/ml); the cells were
incubated with LH for 90 min.

If ouabain treatment depended on an increase in

phosphodiesterase activity for its inhibitory effects, treatment with IBMX
should reverse the inhibition.

In cells treated with IBMX, ouabain inhibition

of LH-stimulated cAMP accumulation was 45 + 2%.

Thus, ouabain did not appear

to exert its inhibitory effect through increased metabolism of cAMP.
Although ouabain inhibited cAMP and progesterone accumulation in a
parallel manner, it is possible that inhibition of progesterone production
occured at a site distal to cAMP accumulation.

To test this possibility,

cells were treated with the membrane permeable cAMP analogue dibutyryl cAMP
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(

(Bu)2-cAMP) after a 20 min. preincubation with ouabain (100yM); tne

incubation was allowed to proceed for 90 min.

As shown in Figure 3,

progesterone accumulation in response to (Bu^-cAMP) was significantly
inhibited in cells pretreatea with ouabain; maximum response to (Bu^-cAMP
was 55 + 1.5 ng./10

5

cells in the absence of the drug and 29+; 0.5 ng/10

5

cells in its presence.
In most tissues, pharmacologic effects of ouabain are attributed to the
glycoside's ability to inhibit the Na+, K+-ATPase (54).

Inhibition of

this pump allows sodium and potassium to diffuse across the plasma membrane
according to their electrochemical gradients.

Because ouabain treatment

diminishes both the sodium and potassium gradients, it was of interest to
consider whether selective interference with either gradient similarly
affected cellular responses.

To this end, two ionophores, monensin and

valinomycin, were tested for their ability to inhibit LH-stimulated cAMP and
progesterone accumulation.

Monensin is a polyether monovalent cationophore

with high selectivity for Na+ transport.

Monensin transports K+ 1/10 as

well as Na+ and also interacts with protons (48).

Valinomycin is a

cyclodepsipeptide which acts specifically as a potassium cationophore.
However, because valinomycin is a neutral compound, valinomycin-K+ complexes
are charged, and potassium diffusion across the cell membrane would be
expected to be limited by the Nernst potential for potassium (48).
Figures 4 and 5 show that both monensin and valinomycin inhibit
LH-stimulated cAMP and progesterone accumulation in significant,
dose-dependent manners.

In the experiment displayed in Figure 4, cells were

treated with monensin for 30 min. before the addition of LH (200 ng/ml).

The
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maximal inhibition of cAMP and progesterone accumulation by monensin was
greater than 60% at a 1 pM concentration of the drug.

The experiment with

valinomycin was performed similarly except that LH concentration was 50
ng/ml.

Maximum inhibition by valinomycin was 60% at 10 nM.

The IC 50 for

monensin was about 0.1 yM: for valinomycin, the IC 50 was less than 10 nM.
Like ouabain, neither drug had a consistent effect on unstimulateo cAMP or
progesterone (Figure 6 for monensin, data for valinomycin not shown).

Figure

6 shows dose-response curves for monensin inhibition in the presence of
increasing doses of LH.

As with ouabain, inhibition by monensin was not

reversed by increased LH concentration.

Monensin inhibition of LH-stimulated

cAMP accumulation was more evident at lower doses of LH (34.5% inhibition with
0.1 yM monensin seen at 50 ng/ml of LH) than at higher doses of LH (21%
inhibition seen at 0.1 yM monensin at 200 ng/ml of LH).
monensin was competitive in nature with a
estimated

Inhibition by

of about 0.06 yM.

The

for monensin-inhibition of LH-stimulated progesterone secretion

was about 0.02-0.04 yM.

These values were obtained from plots of reciprocal

response against drug concentration as explained above for ouabain.
Neither monensin (0.2 yM) nor valinomycin (2 nM) significantly affected
cell viability as judged by trypan blue exclusion or LDH release (data not
shown).

When tested for reversibi1ity of drug effect in a protocol identical

to that described above for ouabain, inhibition of cAMP and progesterone
accumulation by monensin (0.2yM) was almost completely reversed (Table 1).
Washing the cells reduced monensin inhibition from 68.4 + 6.3% to 2 + 0.3% for
cAMP and from essentially 100% inhibition of stimulated progesterone levels to
super-control levels.

Inhibition of cAMP accumulation by valinomycin (2 nM)
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was surprisingly enhanced by the washing procedure; washed samples were
inhibitied 53.8 + 3.8% whereas retreated samples were inhibited by only 18.1 +
1.5%.

Washing did, however, substantially reduce valinomycin inhibition of

progesterone accumulation from 83 + 26% to 20 + 0.9%.

All differences were

significant (p <0.05).
The effect of a 20 min. preincubation with monensin (0.2 uM) or
valinomycin (4 nM) on the binding and uptake of [
was also tested.
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I]-hCG by luteal cells

Neither drug significantly altered the binding of labeled

hormone or competition for binding of radiolabeled hormone by unlabeled
hormone (data not shown).

Table 3 shows the result of an experiment in which

the ability of monensin to inhioit the activity of adenylate cyclase in luteal
membrane preparations was tested.

Like ouabain, monensin (1 uM) did not

inhibit basal or LH-stimulated levels of cAMP in this assay system.
Valinomycin was not tested in membrane preparations.
Neither monensin nor valinomycin appeared to exert their influence on
LH-stimulation by increasing the activity of phosphodiesterase.

After a 10

min. pre incubation with IBNlX (100 uM), cells were treated with monensin (0.2
uM) or valinomycin (2 nM) for 20 min. before incubation with LH (100 ng/ml)
for 90 min.

Both drugs markedly inhibited LH-stimulated cAMP accumulation in

the presence of IBMX: inhibition by monensin was 44 + 3.4% and inhibition by
valinomycin was 28 + 0.8%.
The ability of these drugs to inhibit progesterone accumulation in
response to (Buj^cAMP was also tested.

Cells were preincubated with

monensin (0.2 uM) or valinomycin (2 nM) for 20 min. before the addition of
(Bu)^cAMP.

Monensin significantly inhibited progesterone accumulation in

.

22

response to (Bu)^oAMP (Figure 7).

Progesterone accumulation in response to

1000 uM (Bu)^"cAMP was inhibited 79.1 + 27.5%.

Unlike ouabain and monensin,

valinomycin had no significant effect on stimulation by the nucleotide.
In an attempt to evaluate the mechanism of inhibition by the three drugs,
it was deemed important to ascertain whether inhibition was dependent on an
effect on transmembrane ion gradients.

Thus, if inhibition by ouabain was

dependent on blockade of the Na+, K+-ATPase and a subsequent increase in
intracellular sodium, the effect of the drug would be expected to depend on
the presence of extracellular sodium.
monensin.

A similar argument can be made for

Valinomycin, whose actions are thought to arise from its capacity

to transport K+ only, should not depend on extracellular sodium for its
inhibitory effects.

To test the sodium dependence of these drugs, media was

prepared in which sodium was replaced isotonically with choline chloride.
composition of amino acids and vitamins were identical to MEM.

The

Figure 8

illustrates the influence of replacing sodium with choline on inhibition by
the three drugs of LH-stimulated cAMP accumulation.

In this figure, the cAMP

response is plotted as % of cAMP levels in cells treated with LH alone (100
ng/ml). Inhibition by ouabai n (100 yM) and monensin (0.2y M) were 24 + 0.4%
and 92.7 + 7.3%, respectively, in sodium replete media.

The inhibition by

these drugs was completely reversed when sodium was replaced by choline.

The

absence of sodium had a much smaller effect on the inhibition by valinomycin
(2 nM); cAMP accumulation was inhibited 62 + 3% in the presence of sodium and
42 + 2% in its absence.

This difference was significant (p < 0.02) .

The preceeding experiments demonstrated that three drugs which interfere
with maintainance of normal transmembrane ionic gradients significantly
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inhibited the response of the luteal cell to LH.

The drugs appeared to be

without effect in membranes preparations and did not affect binding and uptake
of hormone by cells.

Both ouabain and monensin have as predominant

pharmacologic mechanisms the ability to increase intracellular sodium
concentrations, although the routes by which the drugs increase sodium levels
differ.

Like PG

(28,29), both drugs inhibited the response to LH at the

level of cyclic AMP accumulation.

The next set of experiments was undertaken

to further localize the molecular site at which ouabain and monensin inhibit
cAMP accumulation.
Binding of cholera toxin to mammalian cell membranes causes
ADP-ribosylation of the N subunit of adenylate cyclase.

This irreversibly

activates the subunit which in turn activates the catalytic moiety.
toxin thereby bypasses the hormone receptor (13).

Cholera

Inhibition of cholera

toxin-stimulated cAMP accumulation must therefore occur at the N or C
subunits.

The ability of ouabain and monensin to inhibit cholera

toxin-stimulated cAMP was tested.

Figure 9 shows the effect of ouabain

(100 yM) and monensin (0.2 yM) on cAMP accumulation in luteal cells stimulated
by cholera toxin.

Cells were incubated with cholera toxin for 2 h.

Ouabain

had no significant effect on cholera toxin-stimulated cAMP production.
Monensin, on the other hand, significantly reduced cAMP accumulation at all
doses of cholera toxin tested.
0.3 pmol/10

5

Maximal cAMP levels were lowered from 2.4 _+

cells in the absence of drug to 1.1 + 0.2 pmol/10

0.2 yM monensin.

5

cells with

The ED 50 for cholera toxin-stimulation was not changed by

monensin treatment.
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Further localization of the inhibition was provided by experiments with
forskolin.

This diterpine has been found to stimulate adenylate cyclase in

all mammalian cells tested, although stimulation of luteal cell cyclase has
not been reported (55).

Stimulation by forskolin is thought to result from

direct activation of the catalytic subunit of adenylate cyclase, bypassing the
hormone receptor and N subunit (56).

The ability of forskolin to stimulate

luteal cell cAMP accumulation is shown in Figure 10.

Like other mammalian

cells, luteal cells respond to forskolin with increased cAMP accumulation.
Maximal stimulation was 5-fold in response to 100yM forskolin.

It is unclear

from the dose-response curve whether higher doses of forskolin would further
increase cAMP accumulation; doses were limited by the solubility of the drug
in ethanol and the need to maintain final ethanol concentration at 1%.
50 for forskolin was about 20 PM.

The ED

Interestingly, forskolin stimulation of

cAMP was associated with only a slight increase in progesterone secretion.

As

seen in figure 11, 100 yM forskolin increased cAMP levels from 0.24 + 0.26 to
3.9 + 0.2 pmol/10

5

cells, but increased progesterone only from 4.0 + 0.4 to

5
5.3 + 0.2 ng/10

cells (p< 0.05) .

In contrast, doses of LH which increase

cAMP only slightly, maximally stimulate progesterone production (11,36).
Luteal cells were treated with ouabain or monensiri for 20 min. before the
addition of forskolin.

Incubation was allowed to proceed for 1 h.

ability of PG F^ to inhibit forskolin stimulation was also tested.
case, PG

was added directly before forskolin.

PG

The
In this

(210 nM) had no

significant effect on forskolin stimulation (Figure 12a): ouabain (100yM) was
also without significant inhibitory effect (Figure 12b).

However, monensin

(0.2 y M) significantly inhibited forskolin-induced cAMP accumulation; maximum
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cAMP levels were reduced from 3.7 + 0.5 to 1.5 + 0.3 pmol/10

5

cells by

monensin but the ED 50 for forskolin did not appear to be affected by drug
treatment.
PG F0

exerts its antigonadotropic action whether added before,

simultaneous with, or after LH (27,57).

We tested whether the order of

addition of drug and hormone was an important factor in expression of the
inhibitory activities of ouabain and monensin.
ouabain (100

pM)

or monensin (0.2

pM)

Cells were treated with

at various times before or after the

addition of LH (200 ng/ml in the case of ouabain, 50 ng/ml for monensin).
Control tubes received media at identical time points and the cells were
incubated with LH for 90 min (Table 4).

If ouabain was added 15 min. before

LH, 48% inhibition of cAMP accumultion was seen.
after LH, ouabain caused only a 12% inhibition.
was not effective.

However, when added 15 min.
Later addition of the drug

Monensin, when added 15 min. before LH, caused 45 + 21.4%

inhibition; inhibition was only 18.5 + 3.2% when added simultaneously with LH,
and 19.6 + 5.3% when added 15 min. after the hormone.
prostaglandin, inhibition

Thus, unlike

of cAMP accumulation by ouabain was only effective

when the drug was added before or simultaneous with LH.
ineffective when added after the hormone.

The drug was

Monensin inhibition was diminished,

but not eliminated when added after LH.
It is possible that activation of adenylate cyclase by LH depends on an
acute ionic influx or depolarization; inhibition by ouabain and monensin could
possibly be explained by prior depletion of the sodium gradient by these
drugs.

If this were the case, pretreatment of cells with LH would render them

refractory to the effects of ouabain and monensin.

This possibility was
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explored in two ways.

First, the dependence of LH-stimulation on the presence

of extracellular sodium was tested.

If stimulation of adenylate cyclase by LH

required influx of sodium, removal of extracellular sodium should inhibit cAMP
accumulation in response to the hormone.

Luteal cells were incubated in media

in which sodium was replaced isotonically with choline chloride as described
in Methods.
min.

LH (100 ng/ml) was added, and the cells were incubated for 90

As seen in Figure 13, reduction of sodium from 128 to 32 meq/1 had no

significant effect on LH-stimulation of cAMP accumulation.

When sodium was

completely eliminated from the medium, maximum cAMP accumulation was reduced
by 30 + 1%.

The ED 50 for LH was not affected by sodium concentration.

We also examined the sodium channel blocker tetrodotoxin (TTX) to test for
a requirement of sodium influx in response to LH.

If LH binding opened a

sodium channel and induced sodium influx which may be necessary for maximal
activation of adenylate cyclase, tetrodotoxin would then be expected to
inhibit the response to LH.

Cells were incubated with TTX for 30 min. at

which time LH (100 ng/ml) was added, and the cells incubated for an additional
90 min.

Doses of TTX as high as 1 uM had no significant effect on basal or

LH-stimulated cAMP levels (data not shown).
Ouabain depolarizes the cell because the Na+, K+-ATPase, an
electrogenic pump, is inhibited resulting in depletion of sodium and potassium
gradients.

Monensin, by virtue of its action as a sodium ionophore would also

be expected to have a cell-depolarizing effect.

To ascertain whether

depolarization per se inhibited LH-stimulation of cAMP accumulation, luteal
cells were incubated in medium in which various concentrations of NaCI were
replaced isotonically with KC1.

Cells were incubated for 90 min. after the
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addition of LH.

The results are shown in Figure 14.

No significant

inhibition was seen with KC1 concentrations as high as 66 mM.
Thus, it appears that inhibition of LH-activation of luteal cells by
ouabain and monensin is dependent on the presence of extracellular sodium, but
the inhibitory effects appear not to be mediated by changes in membrane
potential.

Pharmacologic actions of ouabain in the heart and other tissues

such as thyroid have been ascribed to an increase in intracellular calcium
levels produced as a consequence of the drug-induced increase in intracel1u1ar
sodium.

The increase in sodium increases sodium-calcium exchange and it may

also inhibit calcium extrusion (58).

We therefore

tested the dependence of

inhibition by the two drugs on the presence of extracellular calcium.

Cells

were incubated in "Ca++-free" medium (medium 1) to which various levels of
calcium were added.

Ouabain (100 yM) or monensin (0.2 yM), were added to the

cells for 20 min. before the addition of LH (100 ng/ml), and incubation
continued for 90 min.
As seen in Table 5, depletion of extracellular calcium reduced the amount
of cAMP produced by luteal cells in response to LH.

In the absence of added

calcium, 3.7 + 0.4 pmol accumulated, as compared to a maximum of 14.4 + 2.6 at
a calcium concentration of 1.5 meq/1.
concentrations were not tested.

The effects of higher calcium

Inclusion of 100 yM EGTA in the incubation

media yielded values which were not different from 0 Ca++ (data not shown).
Unstimulated levels of cAMP accumulation also increased with calcium
concentration, rising from 0.96 + 0.3 pmol at 0 Ca++ to 4.0 + 2.0 at 1.5
meq/1.

In the absence of calcium, neither ouabain nor monensin inhibited cAMP

accumulation, however both drugs elicited significant inhibition when calcium
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was replaced.

At 1.5meq/l, ouabain inhibition was 90.4+ 0.7%.

Inhibition

by monensin was not significant at 0.5 meq/1 Ca +, but was below
unstimulated levels at 1.5 meq/1.

In preliminary experiments, the effect of

calcium depletion on valinomycin inhibition was tested.

Valinomycin (4 nM)

did not inhibit LH-stimulated cAMP accumulation in the absence of calcium, but
was maximally inhibitory (80%) at 0.5 meq/1 Ca++ (data not shown).
Because inhibition by ouabain resembled the antigonadotropic effect of
PG F0 , it was of interest to determine whether inhibition by ouabain or
2a

monensin was additive with prostaglandin.
(50-100
of PG F0
min.).

yM)

or monensin (0.1-0.2

for 20 min. at which time various doses

were added and LH (100 ng/ml) added immediately thereafter (90
The results are shown in Figure 15.

treatment, PG F0
ID 50 of 21 nM.
levels.

yM)

Cells were treated with ouabain

In the absence of other drug

inhibited the LH-stimulated accumulation of cAMP with an
At 210 nM, cAMP accumulation was reduced to unstimulated

Addition of a submaximal concentration of ouabain (50^M) shifted the

dose-response curve for PG F^ to the left, causing maximal inhibition at a
concentration of prostaglandin of 2.1 nM.

Similarly, the presence of monensin

potentiated the inhibition produced by PG F^, with maximal inhibition at
2.1 nM PG F0

(0.1 yM monensin) .

PG F_

also changed the dose-response

characteristies of ouabain and monensin; in the presence of 2.1 nM PG F^,
maximal inhibition by ouabain was seen at 50 vi M rather than 100 yM.

This dose

of prostaglandin also augmented the inhibition by a submaximal dose of
monensin (0.1

yM),

increasing inhibition from 5.3 + 4.4 to 100%.

Combinations

of maximal doses of prostaglandin and ouabain or monensin proved to be less
inhibitory than either agent alone.

At 210 nM PG F^a and 100 yM ouabain.
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inhibition was 43.6 + 4.6%; inhibition with this concentration of
prostaglandin and 0.2 yM monensin was 77.2 + 4.8%.
The augmentation of inhibition by ouabain and monensin with PG F0
raised the question of whether inhibition by prostaglandin shared a common
pharmacologic mechanism with ouabain or monensin.
possible that PG

In particular, it was

exerted its anti gonadotropic effect by increasing

intracellular sodium, either by opening specific sodium channels or by
inhibition of the Na+, K+-ATPase.

To test this, cells were incubated in

media in which sodium was replaced isotonically with choline chloride.

LH

(100 ng/ml) was added followed directly by various concentrations of PG F^
and the incubation continued for 90 min.

As seen in Figure 16, the

dose-response characteristics of PG F^ were not significantly affected by
reduction of sodium levels to as low as 10 meq/1.

In sodium-replete medium,

210 nM prostaglandin inhibited LH-stimulated cAMP accumulation to 33 + 8.3% of
control values; in low sodium medium, cAMP was reduced to 24.6 + 6.3% of
control values.
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DISCUSSION
The present studies provide evidence that the response of the rat luteal
cell to luteinizing hormone is extremely sensitive to changes in transmembrane
ionic gradients.

Three drugs which would be expected to perturb the normal

gradients produce significant, dose-dependent inhibition of LH-stimulated cAMP
and progesterone accumulation.

The drugs possess different pharmacologic

properties and would therefore be expected to influence the physiology of the
cell in different ways.

Ouabain, a cardiac glycoside, inhibits the activity

of the Na , K -ATPase (54); sodium would be expected to diffuse into and
potassium out of the cell according to their electrochemical gradients in
absence of pump activity.

Thus, both gradients would be substantially

depleted, and the membrane potential decreased (54).
Monensin, a polyether carboxylic acid, is an ionophore with high
specificity for sodium ions.
potassium, transporting K

+

Th ionophore also possesses some affinity for
+

about 10% as well as Na ; monensin is also

capable of transporting protons (48).

Thus, the net result of treatment with

monensin would be to allow sodium into the cell in exchange for potassium and
protons.

The resultant equilibrium levels of ionic concentrations and

membrane potential would be dependent on the relative rates of ionophorous
transport and pump activity of the Na+, K+-ATPase.
shown to increase Na

Monensin has been

uptake in neuroblastoma-glioma hybrid cells (59).

Valinomycin, on the other hand, is a neutral ionophore specific for K+; as
such, valinomycin would be expected to allow potassium to diffuse out of the
cell.

Since the valinomycin-K+ complex is charged, the extent of potassium

diffusion is limited by the Nernst potential for K+, and valinomycin
treatment should hyperpolarize the cell membrane (48).
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Each of the three drugs inhibited LH-stimulated cAMP and progesterone
accumulation in a significant, dose-dependent fashion.

The ID 50 for each

drug was consistent with or lower than doses used to effect changes in other
systems.

These doses were 50 yM for ouabain, less than 1 yM for monensin, and

less than 1 nM for valinomycin.
each drug.

Maximum inhibition was greater than 50% for

None of the drugs had a consistent effect on unstimulated levels

of cAMP or progesterone, although occasional slight stimulation or inhibition
was seen.

The lack of effect of drug treatment on trypan blue exclusion or

LDH release indicates that the inhibition was not due to decreased cell
viability.
The studies on the reversibility of the effect of these three drugs
yielded somewhat inconclusive results.

Washing decreased ouabain inhibition

of cAMP accumulation from 67 to 37% although progesterone inhibition was
reduced from 75 to 17%.
slow, with a t-j^

The dissociation of the rat ouabain-ATPase complex is

5 min. in the absence of physiological ion

concentrations; with the addition of monovalent cations, the tis
increased 5-fold (60).

The relatively brief washings used in this study (5

min.) were most likely insufficient to allow complete dissociation of the
ouabain-ATPase complex.
readily reversible.

The effect of monensin, on the other hand, was more

Inhibition of cAMP was reduced from 68 to 2%, and

progesterone inhibition was quantitatively reversed by the washing procedure.
Washing paradoxically increased the inhibitory potency of valinomycin with
regard to cAMP accumulation.

Although this drug's lipophilic nature might

make simple washing inadequate to remove the drug from cell membranes, the
inhibition of progesterone accumulation did decrease from 83 to 20% by
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washing.

Thus, the increase in inhibitory potency for cAMP raises the

questions of whether valinomycin treatment allows some essential component or
cofactor of the adenylate cyclase system to leave the cell upon washing and
centrifugation.

Recent studies have shown that under certain circumstances,

cAMP production in luteal cells is limited by the availability of purines for
ATP synthesis (40).

However, treatment with adenosine does not reverse

valinomycin inhibition making this an unlikely explanation (Gore and Behrman,
unpublished observations).
It was somewhat surprising that these drugs displayed similar
dose-response curves for inhibition of cAMP and progesterone accumulation.
There is a dissociation in dose-response character!’sties of LH-stimulation of
cAMP and progesterone secretion in luteal cells so that progesterone is
maximally stimulated at doses of LH which produce very small increments in
cAMP (11,36).

Thus, a 50% inhibition of cAMP accumulation would not be

expected to be associated with a 50% inhibition of progesterone secretion as
seen with these three drugs.

The experiments in which (Bu)^cAMP was used to

stimulate progesterone secretion revealed that ouabain and monensin inhibit
progesterone secretion at a step distal to cAMP production in addition to
their effects on cAMP accumulation. The reason for parallel inhibition by
valinomycin remains unexplained since valinomycin did not significantly affect
progesterone production stimulated by exogenous cyclic nucleotide.

It is

possible that valinomycin treatment specifically inhibits adenylate cyclase
moities which may be directly linked to steroidogenesis.

That steroidogenic

and nonsteroidogenic cyclases might exist is suggested by the fact that
forskolin stimulates luteal cAMP accumulation while having little effect on
progesterone accumulation (Figure 11).
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Because of the variety of changes in cell physiology which might result
from manipulation of ionic gradients, it is impossible to assign a priori
pharmacologic mechanisms responsible for the antigonadotropic effect of the
drugs.

Replacement of the sodium in the medium by choline demonstrated that

the inhibition produced by ouabain and monensin was absolutely dependent on
the presence of extracellular sodium (Figure 8).

This indicates that in the

case of ouabain, inhibition is not due merely to blockade of the ATPase, but
rather to the resultant ionic changes, in particular, the influx of sodium
according to its electrochemical gradient.

Similarly, the sodium dependence

of monensin inhibition is consistent with the drug's high selectivity for
sodium over other cations (48) and again indicates that increasing
intracel1ular levels of sodium antagonizes the effect of LH.

This may be a

direct effect of the sodium, or may be a consequence of some other change in
cellular physiology triggered by the increase in sodium concentration.

The

potassium ionophore, as expected, did not depend on extracellular sodium for
its inhibitory action, although the inhibition by valinomycin was decreased to
a small extent by sodium depletion.

The mechanisms by which increased

intracellular sodium might antagonize LH-stimulation are discussed below.
Binding and uptake of hormone by intact cells was not affected by drug
treatment.

Binding studies with intact cells would appear more appropriate

than membrane binding studies as the ability of these drugs to produce changes
in ionic gradients depends upon the maintainance of membrane integrity with
preservation of sidedness.
binding of [

Moreover, in preliminary studies, no inhibition of

I]-hCG to luteal membranes was seen in the presence of drug

treatment (data not shown).

Neither ouabain nor monensin inhibited basal or
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LH-stimulated cAMP production in membrane preparations; hence, these drugs do
not interact directly with the adenylate cyclase complex.

However, one cannot

conclude that in intact cells, the changes in ionic composition do not affect
the N subunit or catalytic moiety of adenylate cyclase directly.

Increasing

the activity of cyclic nucleotide phosphodiesterase was considered not to be a
major action of these drugs as inhibition of this enzyme by IBMX did not
reverse the effect of drug treatment on cAMP accumulation.
The loci of inhibition of cAMP accumulation by ouabain and monensin were
defined more precisely by stimulating cells with cholera toxin and forskolin.
Ouabain had no significant effect on cAMP accumulation in response to cholera
toxin.

Monensin, however, did reduce maximal cAMP levels by greater than 50%

but had no effect on the ED 50 for cholera toxin-stimulation.

As noted above,

cholera toxin activates adenylate cyclase through covalent modification of N
(13).

Because cholera toxin-stimulated cAMP accumulation is not affected by

ouabain, ouabain inhibition is most likely exerted at a step proximal to
activation of N.

Moreover, because ouabain has no effect on LH binding and

uptake, it would appear that the glycoside inhibits functional coupling of the
occupied hormone-receptor complex to adenylate cyclase.

In this regard,

ouabain inhibition resembles the action of PG F^a which decreases
LH-stimulated cAMP production but has little effect on cholera
toxin-stimulated cAMP levels (30).

The ability of monensin to inhibit cholera

toxin-stimulated cAMP accumulation indicates that the inhibition by this drug
may be elicited at N or a site distal to activation of N.

The possibility

that monensin inhibits the binding of the toxin or subsequent modification of
N by the toxin cannot be excluded by the present experiments.

Inhibition of
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cholera toxin-stimulated cAMP production does not preclude an additional
influence of monensin at the level of receptor-N interaction.
The diterpene forskolin activates adenylate cyclase in all mammalian cell
types tested.

Forskolin enhances ligand-stimulated cylcase activity and also

markedly activates cyclase in the absence of ligand (55).

Because forskolin

elevates cAMP levels in the eye mutant S49 lymphoma cells which lack a
functional N subunit, the drug is presumed to directly stimulate the catalytic
subunit of adenylate cyclase (56).

It is not surprising that forskolin

stimulates cAMP accumulation in isolated luteal cells (Figure 10).
stimulated cAMP accumulation 5-fold.

Forskolin

Although the maximum stimulation and ED

50 cannot be precisely determined from the current data, the dose range at
which forskolin was effective (10-100 yM) is consistent with its use in other
systems (55).
Ouabain had no effect on forskolin-stimulated cAMP accumulation (Figure
12A).

This finding is consistent with the lack of effect of the glycoside on

cholera toxin-stimulated cAMP accumulation.

On the other hand, monensin

inhibited forskolin-stimulated cAMP accumulation by 50% (Figure 12B).
Monensin treatment would therefore appear to inhibit cAMP accumulation by
changes in the sodium gradient which directly influence the catalytic moiety
of adenylate cyclase.

This finding is consistent with inhibition of cholera

toxin-stimulated cAMP accumulation; however, it does not preclude additional
effects of monensin treatment at points proximal to the catalytic subunit.
Although both ouabain and monensin require extracellular sodium and calcium to
express thier inhibitory activities, the experiments with cholera toxin and
forskolin illustrate that a difference in the inhibitory activity of the two
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drugs exists.

This discrepancy may reflect differences in the extent to which

the two drugs increase intracellular Na+ or Ca++ levels and the
dose-response characteristics of the cations themselves.
The effect of PG F,.

2a

tested.

on forskol in-stimulated cAMP levels was also

Like ouabain, PG

had no effect on the binding and uptake of

hCG, and had little or no effect on cholera toxin-stimulated cAMP accumulation
(28,30).

PG F^

also did not inhibit forskolin stimulation of cAMP

accumulation (Figure 12B), lending further support to the conclusion that
PG F^a appears to functionally uncouple the LH-receptor complex from
adenylate cylase (61,71).
The inability of forskolin to substantially increase progesterone
production at doses which lead to cAMP levels otherwise associated with
maximal progesterone secretion (Figure 11) raises important questions about
the functional relationship between cAMP levels and steroidogenesis in the
luteal cell.

Like forskolin, cholera toxin stimulates luteal steroidogenesis

only slightly while markedly elevating cAMP to levels which, if induced by LH,
would maximally stimulate progesterone production (30).

Similar results have

been seen with stimulation of rat leydig cells by cholera toxin (62).

As

discussed in the introduction, in luteal, adrenal cortical and other cells,
the dose of trophic hormone required to produce half-maximal end response (in
this case, progesterone accumulation) is considerably less than that which
elicits the half-maximal cAMP response (11,12,36).

Long attributed to "spare

receptors", the additional cAMP made at high hormone concentrations may serve
other cellular functions (12).

The failure of forskolin and cholera toxin to

stimulate progesterone secretion raises the further question of whether
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different classes of adenylate cyclases exist such that the cAMP produced in
response to LH gains priveleged access to the steroidogenic processes.
Non-sepcific stimulation of many different cyclase complexes by cholera toxin
or forskolin would lead to high levels of cAMP but only some of this would be
directed to protein kinases which stimulate steroid production.

Abramowitz

and Birnbaumer have concluded that there is only one class of adenylate
cyclase in the luteal membrane because the stimulatory effects of LH and
3-adrenergic agents are not additive (14).

These studies were carried out in

membrane preparations and therefore cAMP production could not be correlated
with steroidogenesis; it is possible that tissue homogenization and membrane
isolation so disrupts the cellular architecture that in situ functional
differences among cyclase molecules cannot be discerned.

Further elucidation

of the relationship between cAMP and steroidogenesis awaits new methodology
which can resolve differences among intracellular pools of cAMP and
demonstrate the presence or absence of selective stimulation and inhibition of
these pools.
There are several routes by which an increase in intracellular sodium
could lead to antagonism of LH-stimulation.

Inhibition could be mediated

directly by an action of sodium on the adenylate cyclase enzyme complex.
Sodium ions reduce receptor binding affinities for cholecystokinin in brain
and pancreas (63) and a-adrenergic, muscarinic, and opiate agonists in brain
(64,65,66).

However, ouabain and monensin had no effect on hCG binding and

uptake in luteal cells.

Sodium ions also promote hormonal inhibition of

adenylate cyclase in various tissues including myocardium and
neuroblastoma-glioma cells (67).

It has been proposed that there is an
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inhibitory N subunit which is linked to adenylate cyclase; the ability of
increased intracellular sodium to antagonize LH-stimulated cAMP production
could be mediated through activation of such a protein (67).

Birnbaumer et al

have reported that luteal adenylate cyclase activity in membranes is inhibited
by sodium but only at doses at which non-specific effects of ionic strength
are seen (10).

However, it is possible that if "sided" membrane vesicle

preparations were made, an increase in [Na+]^n might prove to specifically
inhibit LH-stimulated cAMP production.
LH-stimulated cAMP levels were markedly reduced when ouabain or monensin
were added simultaneous with or preceeding LH (Table 4).

In the case of

ouabain, addition of the drug before or together with LH led to 48%
inhibition, whereas addition 15 min. following the hormone led to only 12%
inhibition.
t-j

The binding of ouabain to the Na+, K+-ATPase is slow, with a

of 10 min. (68).

Additionally, some time must be required for the

subsequent passive depletion of sodium and potassium gradients.

Thus, when

ouabain is added after LH, considerable amounts of cAMP might accumulate
before ouabain takes effect.

Alternatively, LH pretreatment may render the

cell resistant to inhibition by ouabain.

Monensin inhibition of cAMP

accumulation was also considerably diminished when the drug was added after
LH.

Monensin action requires diffusion of the drug into the membrane, after

which the ionophore acts as a pore, allowing sodium to diffuse into the cell.
Thus, monensin may not require as long a latent period for activity as
ouabain.

It seems likely that LH pretreatment has a protective effect against

monensin inhibition.

In contrast, PG F0

even when added 60 min. after LH (57).

effectively antagonizes LH action
In this respect, ouabain and monensin
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inhibition differ from that of prostaglandin.

The binding of hCG to LH

receptors is essentially irreversible at 37°C (69).

It is tempting to

postulate that coupling of occupied LH receptors to cyclase is also not easily
reversed, a phenomenon which may diminish ouabain and monensin action after LH
addition.

It is currently thought that hydrolysis of GTP by the N subunit

inactivates ligand-stimulated adenylate cyclase while decreasing the affinity
of the receptor for ligand (70).

However, GTP does not change the affinity of

the LH receptor for gonadotropin as it does for ligand receptors in other
cyclase systems (71,72,73); LH-stimulated adenylte cyclase may be inactivated
by other means, such as internalization of the hormone-receptor complex.
Increasing intracellular sodium levels depolarizes the cell membrane.

It

is conceivable that a negative membrane potential is needed for effective
stimulation of adenylate cyclase by LH.

For example, if maximal stimulation

by LH required an acute influx of sodium or calcium through receptor-mediated
channels, chronic depolarization might inactivate such channels.

This seems

unlikely as Higuchi and colleagues showed through direct intracellular
recording of luteal cell membrane potential that LH did not change membrane
potential (46).

In these studies, depolarization by high concentrations of

potassium actually increased progesterone secretion; cAMP was not measured.
Recently, however, adrenocortical cells have been demonstrated to undergo
depolarization in response to ACTH; this depolarization appears to be due
primarily to calcium influx (74).
If an acute ionic flux or depolarization were required for full activation
of adenylate cyclase by LH, this might explain the diminished effect of
ouabain and monensin following LH addition as these drugs induce chronic
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depolarization.

However, substantial reduction of the sodium gradient by

decreasing extracellular sodium to 32 meq/1 had no effect on LH stimulation
(Figure 13).

The sodium channel blocker tetrodotoxin also had no effect on

LH-stimulation.

This does not exclude a role for sodium influx in

LH-stimulation as TTX appears to block potential-dependent sodium gates;
receptor-mediated sodium permeability changes such as in post-synaptic
membranes are not blocked by TTX (75,76).

However, depolarization of luteal

cells by high extracellular potassium concentrations had no effect on
LH-stimulated cAMP accumulation (Figure 14).

Since sodium channels would be

expected to be inactivated by chronic depolarization, a role of acute ion flux
in LH-stimulation is unlikely.

The present results also show that

depolarization does not increase luteal cAMP accumulation (Figure 14).

As

depolarization appears to increase luteal steroidogenesis (46), this may
indicate that there are additional factors regulating luteal steroidogenesis
which mediate depolarization-induced progesterone accumulation.

There is

ample evidence in the adrenal cortex that calcium is required for steroid
biosynthesis; both depolarization and ACTH stimulate calcium influx (12).
Increasing intracellular sodium often leads to a secondary increase in
intracellular calcium (77).

There is considerable debate as to whether this

results from an increase in sodium-calcium antiport, inhibition by
intracellular sodium of calcium extrusion, or a decrease in intracellular
calcium sequestration; it is likely that in various cell types and under
different conditions each mechanism may play a role (58).

It is generally

agreed that the inotropic action of ouabain results from a secondary increase
in intracellular calcium (54).

Calcium ions could be responsible for
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inhibiting LH-stimulated cAMP production.

Dorflinger and Behrman reported

that two hour incubations of luteal cells with the calcium ioriophore A23187
antagonized the effects of LH; this inhibition required the presence of
extracellular calcium (31).

Ouabain decreases thyrotropin-stimulated cAMP

accumulation in canine thyroid slices; this effect was partially reversed by
*f +

Mn

ions, but was not dependent on the presence of extracellular calcium

(78).

The authors suggested that the inhibition was mediated by decreased

sequestration of intracellular calcium or release of calcium from organelles
in response to the increased intracellular sodium.
Current experiments in which the concentration of extracellular calcium
was varied point to a complicated role for this cation in luteal physiology
(Table 5).

LH stimulates cAMP production in the absence of extracellular

calcium; replacing calcium increases both stimulated and basal cAMP levels.
Maximum cAMP levels in response to LH were seen at 1.5 mM calcium.
Extracellular calcium thus appears to enhance LH-stimulation of cAMP but it
does not appear to be obligatory.

It is not clear from the present study

whether this effect of calcium is strictly extracellular, for instance by
enhancing binding of hormone, or whether LH-stimulation actually depends on a
calcium influx.

Extracellular calcium has similar effects on cAMP production

in adrenal cells stimulated by ACTH (79,80) and C-6 glioma cells stimulated by
norepinephrine (81).

However, as noted, A23187 treatment inhibits LH

stimulated cAMP levels (31).

It is possible that low levels of cytoplasmic

calcium enhance LH-stimulated cAMP production while higher concentrations
inhibit cyclase directly.

Such biphasic modulation of adenylate cyclase

activity by calcium has been demonstrated in brain tissue.

A
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calmodulin-sensitive adenylate cyclase has been shown to be stimulated by
micromolar calcium concentrations and inhibited by higher concentrations of
calcium (82).

Calcium is not required to elicit LH-stimulation of adenylate

cyclase activity in luteal membranes (10).

However, luteal membranes have

required superphysiological doses of LH to generate cAMP, and the absence of
calcium may contribute to this (10) .

Millimolar concentrations of calcium

inhibit LH-stimulated cyclase activity in membranes (31).

It is possible that

under appropriate circumstances, for instance with the addition of calcium and
calmodulin, a direct role of calcium in physiological concentraions on
LH-sensitive adenylate cyclase will be demonstrated in membrane preparations.
Aside from inhibiting adenylate cyclase directly or via calmodulin, increased
cytoplasmic calcium could stimulate phospholipase A^ or C, producing
prostaglandins or phosphatidyl inositol metabolites which could mediate the
inhibition of adenylate cyclase.

A similar mechanism could explain A23187

inhibition.
Because replacing extracel1ular calcium enhances LH-stimulated cAMP
accumulation, the role calcium plays in mediating ouabain and monensin
inhibition remains ambiguous.

In the absence of extracel1ular calcium neither

drug affects LH-stimulated cAMP production; replacement of calcium allows the
inhibitory activity of the drugs to be expressed (Table 5).
possible interpretations for these results.

There are two

One is that LH-stimulation of

cAMP has two components, one calcium-dependent and one calcium-independent.
If ouabain and monensin inhibit the calcium-dependent component, the
inhibition by the drugs would not be observed in the absence of calcium.

It

is also possible and perhaps more likely that the increase in intracellular
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sodium provided by ouabain and monensin treatment leads to an influx of
extracellular calcium and this leads directly or indirectly to inhibition of
LH-stimulated cAMP production.
A23187.

This would be consistent with the effects of

The inhibition of LH-stimulation seen by complete removal of sodium

from the medium (Figure 13) could also be explained by a rise in intracellular
calcium mediated by sodium-calcium exchange induced by a reversal of the
sodium gradient (77).
PG F^a does n°t require extracellular calcium for its antigonadotropic
activity (57).

The effects of low doses of PG F^a and ouabain or monensin

are superadditive, although combinations of high doses of prostaglandin with
either drug are less inhibitory than either treatment alone (Figure 15).

This

additivity at low doses may indicate that ouabain and monensin share a common
mechanism of inhibition with PG F^a.

However, PG F^a was equally potent

in the presence and absence of extracellular sodium (Figure 16).

It is thus

highly unlikely that PG F^a increases intracellular sodium as a primary
mechanism of inhibition.
intracellular stores.

PG F^a may, however, release calcium from

If inhibition by ouabain and monensin are mediated by

calcium, additivity would be predicted.

It is also possible that some or all

of the inhibition produced by ouabain and monensin is due to synthesis of
prostaglandin.

There are differences between the inhibitory activities;

PG F2Ct is active whether added before or after LH (57), whereas ouabain and
monensin are less active when added after LH.

Monensin appears to lead to

inhibition of the catalytic subunit of adenylate cyclase, while PG F0 and
ca
ouabain appear to uncouple the hormone-receptor complex from N.

If ouabain

and monensin activity were due exclusively to synthesis of prostaglandin, one
would expect activity but not superadditivity with low doses of PG F^ .
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Ouabain treatment in different cell types affects cyclic nucleotide levels
in various ways.

As noted above, in thyroid tissue, ouabain decreases

TSH-stimulated cAMP accumulation (78).

In cultured fetal rat bones, ouabain

increased basal and PTH-stimulated cAMP levels (83) but had no effect on PG
F0 -stimulated cAMP accumulation in cultured bone cells (84).
l a

Ouabain also

increases cAMP levels and insulin secretion in isolated pancreatic islet cells
(85) .

Monensin stimulates catecholamine secretion in adrenal chromaffin cells

(86) and in pheochromocytoma cells (87) and increases spontaneous and evoked
transmitter release in the frog neuromuscular junction (88).

In both adrenal

and pheochromocytoma cells, the effect of monensin required extracellular
sodium but not calcium.
monensin on cAMP levels.

There have been few reports of the effects of
In sea urchin spermatozoa, high concentrations of

the ionophore (25 vM) stimulate cAMP accumulation in a sodium-dependent
fashion (89).
The mechanism of the antigonadotropic effect of valinomycin is not
obvious.

Valinomycin treatment should result in hperpolarization of the

membrane as noted above; this would increase the electrochemical gradient for
both sodium and calcium.

Valinomycin inhibition is only slightly dependent on

extracellular sodium (Figure 8).

Preliminary experiments indicate that

inhibition by valinomycin is, however, dependent on the presence of
extracellular calcium (data not shown).

This lends support to the possibility

that a primary step in inhibition of LH-stimulated cAMP accumulation by all
three drugs in an increase in intracel1ular calcium.
It seems likely that increased intracellular calcium, produced by a
variety of pharmacologic manipulations, inhibits the response of the luteal
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cell to LH in agreement with earlier findings using the calcium ionophore
A23187 (31).

Direct confirmation of this hypothesis will require the use of

labeled calcium to study calcium flux in response to drug treatment.
Inhibition by calcium might be mediated directly at the adenylate cyclase
complex as suggested by preliminary studies which showed inhibition of
LH-stimulated cAMP in membrane preparations by millimolar levels of calcium
(31).

Alternatively, calcium influx could lead to the activation of

phospholipases whose reaction products-prostaglandins, leukotrienes or
phosphatidyl inositol metabolites-antagonize LH action.

Additionally the

effects of calcium may be related to changes in membrane fluidity, consistent
with the x-ray diffraction experiments of Carlson and colleagues (42,43,44).
Precise explication of the role of calcium in LH-activation and inhibition
of LH-activation will require experiments with membrane preparations testing
the effects of calcium, calmodulin, calmodulin inhibitors or antibodies, on
LH-stimulated cAMP production. As LH-stimulation is blunted in the absence of
extracellular calcium, it seems likely that under appropriate experimental
conditions, LH-sensitive adenylate cyclase will be stimulated at low calcium
concentrations, but will be inhibited by higher concentrations, similar to
some cyclase systems in brain (82).

Additional experiments with inhibitors of

phospholipases and cyclo- and lipo- oxygenase would help determine whether
production of fatty acid-derived mediators is an important consequence of
calcium influx in the luteal cell.
The luteal cell is unique as it becomes desensitized to LH spontaneously
during its brief lifetime.

The ability of three ion-active drugs to

profoundly inhibit the response of luteal cells to luteinizing hormone
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indicates that maintainance of the usual ionic gradients is critically
important to luteal steroidogenesis.

Indeed, the competitive actions of these

drugs and natural substances such as PG

and GnRH against LH may indicate

that one of the luteotropic actions of LH may be to maintain optimum
electrochemical ionic gradients in the luteal cell and to preserve low
intracellular levels of calcium.

This conclusion is supported by results of

the present studies which showed that ouabain and monensin were inactive in
cells pretreated for about 30 min. with LH.

Consequently, LH may rescue the

corpus luteum from regression by preventing an increase in intracellular
calcium which may be the initial event in the luteolytic process.

Detaiiled

investigation into the effects of calcium on the luteal adenylate cyclase
complex may yield important information about luteolysis, receptor-cyclase
coupling and modulation of cellular response to extracellular messengers.
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Table 1. Reversibility of inhibition of LH-stimulated cAMP and progesterone
accumulation by ouabain, monensin and valinomycin.

cAMP
Treatment

Progesterone
Drug Treated

Drug Treated
and Washed

Drug Treated

% Inhibition

Drug Treated
and Washed

% Inhibition

Ouabain
(100 p M)

67.3 + 7.1

36.8 + 3.7a

75.7 + 2.7

17.8 + 2.8a

Monensin
(0.2yM)

68.4 + 6.3

2.2 + 0.3a

100

-25.7 + 2.9ab

Valinomycin
(2 nM)

18.1 + 1.5

53.3 + 3.8a

82.8 + 23.8

20.2 + 0.8a

Cells were incubated with drugs at the indicated concentrations for 15 min, the
media was aspirated following centrifugation (100 g; 5 min), fresh media with and
without drugs was added, the cells were resuspended and incubated for an additional
5 min. The washing procedure was then repeated. The cells were resuspended in
fresh media with and without drugs and incubated for 5 min, following which LH
(100 ng/ml) was added and the incubation continued for an additional 90 min.
Values are the mean + SEM of four replicates, expressed as percent inhibition of
control LH stimulated. aSignificantly different from washed and retreated
(p <0.05). bWashed values greater than control
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Table 2.

Effect of ouabain on adenylate cyclase activity in luteal membranes.

cAMP (pmo1/mg/min)

[LH] (ng/mlj

Control

0

8.1 + 1.3

6.8 + 0.5

50

11.0 + 1.1

14.2 + 1.3

100

21.3 + 4.0

21.0 + 4.0

Values are the mean + SEM of four replicates.

Ouabain
(100uM)

.

56

Table 3.

Effect of monensin on adenylate cyclase activity in luteal membranes.

cAMP (pmo1/mg/min)

[LH] (ng/ml)

Control

Monensin
(1 uM)

0

1.0 + 0.6

1.5 + 1.3

50

10.2 + 1.6

100

13.7 + 1.0

Values are the mean + SEM of four replicates,
(p > 0.05).

6.8 + 1.7a
13.7 + 1.2

difference not significant
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Table 4. Effect of time of addition of ouabain or monensin on inhibition of
LH-stimulated cAMP accumulation.

Time of addition
of drug
(mi n)

-60

Inhibition of cAMP
Ouabain
(100UM)

*37.9 + 2.4
*49.7 + 3.8

-30
-15

Accumulation (%)
Monensin
(0-2U M)

*48.0 + 0.1

*45.0 + 2.4

*48.7 + 2.7

*18.5 + 3.2

15

*12.0 + 3.1

*19.6 + 5.3

30

1.4 + 5.0

*11.4 + 1.7

60

5.5 + 4.7

-26.7 + 1.9a

0 (LH added)

Values are the mean + SEM of four replicates expressed as percent inhibition
of LH-stimulated levels (LH = 200 ng/ml for ouabain and 50 ng/ml in monensin
experiment). *p < .05 compared to LH control. At the indicated times drug or
media alone was added. aValue greater than LH control. All incubations
with LH in the presence of drugs were of 90 min. duration.
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Table 5. Effect of calcium depletion on LH-stimulation of cAMP accumulation
and on inhibition of LH-stimulation by ouabain and monensin in luteal
cel Is.

0

CaCl2 (mM)
0.5

1.5

Contro 1

1.0 + 0.3

1.0 + 1.6

4.0 + 1.0

LH (100 ng/ml)

3.7 + 0.4

6.7 + 0.9

14.4 + 2.6

LH + Ouabai n (100 pM)

3.8 + 1.0

4.0 + 0.3* *

6.1 + 1.1*

5.0 + 1.1

8.4 + 0.3

2.6 + 0.3*

Treatment

LH + Monensin (0.2 p M

)

Cells were dispersed and enriched in Ca^+ -free media (see Materials and
Methods) and incubated in the same media to which the indicated concentrations
of CaCl2 was added. Cells (10^) were preincubated with ouabain or
monensin for 20 min prior to addition of LH; drugs and LH were coincubated
with the cells for 90 min. Each value is the mean + SEM of 4 replicates.
*p < .01 compared to LH treatment alone.
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FIGURE 1. Dose-response effect of ouabain on LH stimulated cAMP and
progesterone accumulation in luteal cells. Cells (10^) were incubated with
ouabain for 1 h, at which time LH was added (200 ng/ml).
Incubation was
continued for 90 min. Each point is the mean + SEM for four replicates. cAMP
accumulation in the absence of LH was 0.2 pmol/105 cells. Progesterone
accumulation in the absence of LH was 21.3 + 1.0 ng/10^ cells.
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FIGURE 2. Effect of LH concentration on inhibition of cAMP and
progesterone accumulation by ouabain in luteal cells. Cells (105) were
incubated with ouabain for 1 h, at which time LH was added.
Incubation was
continued for 90 min. Each point is the mean + SEM of four replicates. A.
cAMP accumulation. B. Progesterone accumulation.
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FIGURE 3.

Effect of ouabain on stimulation of progesterone accumulation

UBU2rC/MP,i" luteal CellS‘
CeUs (105> “ere incubated with ouabain
(100 uM) for 30 min. before the addition of (Bu)2-cAMP.
Incubation was
continued for 90 min. Each point represents the mean + SEM of four
replicates.
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FIGURE 4. Dose-response effect of monensin on LH-stimulated cAMP and
progesterone accumulation in luteal cells.
Cells (10^) were incubated with
monensin for 30 min. before the addition of LH (200 ng/ml).
Incubation was
continued for 90 min. Each point represents the mean + SEM of four
replicates. cAMP accumulation in the absence of LH was 0.1 pmol/10^ cells.
Progesterone accumulation in the absence of LH was 3.7 + 0.6 ng/10^ cells.
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FIGURE 5. Dose response effect of valinomycin on LH-stimulated cAMP and
progesterone accumulation in luteal cells.
Cells (10^) were incubated with
valinomycin for 30 min. before the addition of LH (50 ng/ml).
Incubation was
continued for 90 min. Each point represents the mean + SEM of four
replicates. cAMP accumulation in the absence of LH was 0.2 pmol/lO^ cells.
Progesterone accumulation in the absence of LH was 15.6 + 0.4 ng/10^ cells.
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FIGURE 6. Effect of LH concentration on inhibition of cAMP and
progesterone accumulation in luteal cells by monensin.
Cells (10^) were
incubated with monensin for 30 min. before the addition of LH.
Incubation was
continued for 90 min. Each point is the mean + SEM of four replicates.
A. cAMP accumulation. B. Progesterone accumulation.
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FIGURE 7. Effects of monensin and valinomycin on stimulation of
progesterone accumulation by (Bu)2-cAMP in luteal cells.
Cells (105) were
incubated with monensin (0.2 uM) or valinomycin (2 nM) for 30 min. before the
addition of (Bu)2-cAMP.
Incubation was continued for 90 min. Each point
represents the mean + SEM of four replicates.
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FIGURE 8. Effect of sodium depletion on inhibition of LH-stimulated cAMP
accumulation by ion-active drugs in luteal cells.
Cells were washed twice in
sodium-replete medium or in medium in which sodium was replaced isotonically
with choline chloride, as described in Methods. Cells (105) were incubated
with ouabain (100yM), monensin (0.2yM) or valinomycin (2 nM) for 30 min.
before the addition of LH (100 ng/ml) . Each value represents the mean + SEM
for four replicates. cAMP accumulation in the absence and presence of LH was
0.07 + 0.03 and 7.1 + 0.3 pmol/10J cells, respectively, in sodium-replete
medium, and 0.07 + 0.04 and 4.2 + 0.2 pmol/10b cells, respectively, in
sodium-aepleted medium. *significantly different from control (p< 0.05).
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EFFECT OF OUABAIN AND MONENSIN ON
CHOLERA TOXIN STIMULATION OF
cAMP ACCUMULATION IN LUTEAL CELLS

CHOLERA TOXIN (nM)

FIGURE 9. Effect of
levels in luteal cells.
monensin (0.2 pM) for 20
Incubation proceeded for
replicates.

ouabain and monensin on cholera toxin-stimulated cAMP
Cells (10^) were incubated with ouabain (100 y M) or
min. before the addition of cholera toxin.
2 h. Each point represents the mean + SEM of four

.

CAMP (pmol/I0® cells)
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FORSKOLIN ifiM)

FIGURE 10. Dose-response effect of forskolin on cAMP accumulation in
luteal cells. Cells (105) were incubated with forskolin for 1 h. Each
point represents the mean +_ SEM for four replicates.
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FIGURE 12.
Effect of ouabain, monensin, and PG F2 on forskolinstimulation of cAMP accumulation in luteal cells. Cells (10^) were
incubated with ouabain (100 pM) or monensin (0.2 pM) for 20 min. before the
addition of forskolin.
PG F2a (210 nM) was added simultaneously with
forskolin.
Incubation proceeded for 60 min. Each value represents the mean +
SEM of four replicates.
—
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LH ( ng/ml )

FIGURE 13. Effect of Na+ concentration on LH-stimulated cAMP
accumulation in luteal cells.
Cells were washed twice with sodium-replete
medium or with medium in which Na+ was replaced isotonically with choline
chloride (see Materials and Methods). Cells (105) were then resuspended in
medium which contained the indicated concentrations of Na+ and incubated
with LH (100 ng/ml) for 90 min. Each point represents the mean + SEM of 4
replicates.
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EFFECT OF EXTRACELLULAR POTASSIUM ON
LH-ST1MULATED cAMP ACCUMULATION

LH (ng/ml)

FIGURE 14.

Effect of depolarization by high extracellular potassium on

in'mPriT ated
levels in lutea1 cells*
Cells were washed and resuspended
rhine^Um 1!1uwhlch sodlum chloride was replaced isotonically with potassium
chloride. LH was added and cells were incubated for 90 min.
Each point
represents the mean _+ SEM for four replicates.
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FIGURE 15.
Combined effects of ouabain or monensin with PG F2a on
LH-stimulated cAMP accumulation in luteal cells.
Cells (105) were incubated
with ouabain (50-100yM) or monensin (0.1-0.2 yM) for 20 min. at which time
PG F2a was added. LH (100 ng/ml) was added directly thereafter and
incubation proceeded for 90 min. Each point represents the mean + SEM of fou
replicates. A. Ouabain.
B. Monensin.
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FIGURE 16. Effect of sodium depletion on inhibition by PG F?„ of
LH-stimulated cAMP accumulation in luteal cells.
Cells were washed and
resuspended in sodium-replete medium or in medium in which sodium was replaced
isotonically by choline chloride as described in Methods.
PG F?„ was added
to cells (10b), and LH (100 ng/rnl) was added directly thereafter.
Incubation proceeded for 90 min. Each point represents the mean + SEM for
four replicates.
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